Nplate 500 MCG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FCRP1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,174
Award facts
- Contract value 100% obligated
- $34,174.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $34,174 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 500 microgram vials of Nplate. This firm fixed-price delivery order, awarded on December 11, 2025, with an ultimate completion date of January 5, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award was issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion Defense Logistics Agency acquisition strategy that establishes multiple regional prime vendor contractors to supply pharmaceutical products to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract under PPV-G GEN V (contract SPE2DR) with a $499,999,999 ceiling and completion date of December 31, 2036, structured with a 30-month base period and three 30-month option periods. This delivery order represents one of numerous firm fixed-price issuances the Defense Logistics Agency has directed to the contractor for specialized pharmaceutical products, including oncology treatments, biologics, vaccines, and medical consumables. The contractor's established performance across diverse therapeutic categories positions it as a critical pharmaceutical supplier supporting the recurring medical supply needs of the military healthcare system.
Quick answers
Who was awarded contract SPE2DR26FCRP1?
SPE2DR26FCRP1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26FCRP1 worth?
The government has obligated $34,174 on SPE2DR26FCRP1.
Is contract SPE2DR26FCRP1 an order under another contract?
Yes. SPE2DR26FCRP1 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRP1 competed?
The extent of competition for SPE2DR26FCRP1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award